Cargando…

Hypercoagulability and Risk of Venous Thromboembolic Events in Endogenous Cushing's Syndrome: A Systematic Meta-Analysis

Background: Hypercortisolism has been implicated in the development of venous thromboembolic events (VTE). We aimed to characterize VTE risk in endogenous Cushing's syndrome (CS) patients, compare that risk to other pathologies, and determine if there are any associated coagulation factor chang...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wagner, Jeffrey, Langlois, Fabienne, Lim, Dawn Shao Ting, McCartney, Shirley, Fleseriu, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360168/ https://www.ncbi.nlm.nih.gov/pubmed/30745894 http://dx.doi.org/10.3389/fendo.2018.00805

Ejemplares similares

Hypercortisolemia Recurrence in Cushing's Disease; a Diagnostic Challenge
por: Hinojosa-Amaya, José Miguel, et al.
Publicado: (2019)

Pituitary-Directed Therapies for Cushing’s Disease
por: Langlois, Fabienne, et al.
Publicado: (2018)

Incidence of Venous Thromboembolic Events in Patients With Endogenous Cushing Syndrome
por: Subbu, Karthik, et al.
Publicado: (2021)

Recent Progress in the Medical Therapy of Pituitary Tumors
por: Langlois, Fabienne, et al.
Publicado: (2017)

Hypercoagulability in Cushing Syndrome, Prevalence of Thrombotic Events: A Large, Single-Center, Retrospective Study
por: Suarez, Maria Gabriela, et al.
Publicado: (2019)

Update on medical treatment for Cushing’s disease
por: Cuevas-Ramos, Daniel, et al.
Publicado: (2016)

FRI111 Venous Thromboembolism In Cushing Syndrome - A Call For Standardized Anticoagulation Regimen In Hypercortisolism
por: Minasyan, Mari, et al.
Publicado: (2023)

Hypercoagulability in ACTH-Dependent Cushing Syndrome
por: Singh Sumal, Amit Kartar, et al.
Publicado: (2021)

Depression and Impulsivity Self-Assessment Tools to Identify Dopamine Agonist Side Effects in Patients With Pituitary Adenomas
por: Hinojosa-Amaya, José Miguel, et al.
Publicado: (2020)

Indicators of hypercoagulability and recurrent venous thromboembolism in the elderly: rethinking age and thrombophilia
por: Middeldorp, Saskia
Publicado: (2023)

Choroidal and Retinal Abnormalities by Optical Coherence Tomography in Endogenous Cushing’s Syndrome
por: Abalem, Maria Fernanda, et al.
Publicado: (2016)

Decreased Trabecular Bone Score in Patients With Active Endogenous Cushing’s Syndrome
por: Stachowska, Barbara, et al.
Publicado: (2021)

Preventive strategies for hypercoagulation in Cushing’s syndrome: when and how
por: Lopes, Valentim, et al.
Publicado: (2023)

Medical Therapy with Pasireotide in Recurrent Cushing’s Disease: Experience of Patients Treated for At Least 1 Year at a Single Center
por: Yedinak, Chris G., et al.
Publicado: (2017)

Hypercoagulability in Cushing’s syndrome: incidence, pathogenesis and need for thromboprophylaxis protocols
por: Feelders, Richard A., et al.
Publicado: (2022)

Functioning Pituitary Adenomas – Current Treatment Options and Emerging Medical Therapies
por: Varlamov, Elena V, et al.
Publicado: (2019)

Levoketoconazole in the Treatment of Patients With Cushing’s Syndrome and Diabetes Mellitus: Results From the SONICS Phase 3 Study
por: Pivonello, Rosario, et al.
Publicado: (2021)

Safety and Efficacy of Subcutaneous Pasireotide in Patients With Cushing's Disease: Results From an Open-Label, Multicenter, Single-Arm, Multinational, Expanded-Access Study
por: Fleseriu, Maria, et al.
Publicado: (2019)

Long-term efficacy and safety of subcutaneous pasireotide alone or in combination with cabergoline in Cushing’s disease
por: Feelders, Richard A., et al.
Publicado: (2023)

Testing for Hypercoagulability in Patients With Unexplained Arterial Thromboembolism
por: Chan, Noel, et al.
Publicado: (2023)

Combined Oral Contraceptives and Venous Thromboembolism: Review and Perspective to Mitigate the Risk
por: Morimont, Laure, et al.
Publicado: (2021)

FRI110 Prevalence Of Thromboembolic Events In 51 Patients Treated For Cushing’s Disease With Pituitary Surgery At University Hospital Of Wales Over A 15-year Period
por: Raj Suresh John, Romesh Paul, et al.
Publicado: (2023)

Metyrapone Versus Osilodrostat in the Short-Term Therapy of Endogenous Cushing’s Syndrome: Results From a Single Center Cohort Study
por: Detomas, Mario, et al.
Publicado: (2022)

Distinct serum steroid profiles between adrenal Cushing syndrome and Cushing disease
por: Gao, Chang, et al.
Publicado: (2023)

Neuropsychiatric disorders in Cushing's syndrome
por: Pivonello, Rosario, et al.
Publicado: (2015)

Hypercoagulability in ICU Patients With Coronavirus Disease 2019 With Respiratory Failure Results in Increased Prevalence of Venous Thromboembolic Disease
por: Long, Sarah A., et al.
Publicado: (2021)

S306: HYPERCOAGULABILITY BIOMARKERS AND THROMBIN GENERATION (TG) PREDICT VENOUS THROMBOEMBOLISM (VTE) IN METASTATIC LUNG CANCER PATIENTS
por: Gomez Rosas, Patricia, et al.
Publicado: (2023)

A New Clinical Model to Estimate the Pre-Test Probability of Cushing’s Syndrome: The Cushing Score
por: Parasiliti-Caprino, Mirko, et al.
Publicado: (2021)

Diabetes Mellitus Secondary to Cushing’s Disease
por: Barbot, Mattia, et al.
Publicado: (2018)

Quality of Life in Patients With Cushing's Disease
por: Santos, Alicia, et al.
Publicado: (2019)

Cushing’s Disease Management: Glimpse Into 2051
por: Dalan, Rinkoo, et al.
Publicado: (2022)

Functional brain alterations in Cushing’s syndrome
por: Papakokkinou, Eleni, et al.
Publicado: (2023)

Recent advances in the medical treatment of Cushing’s disease
por: Fleseriu, Maria
Publicado: (2014)

The Pathophysiology and Treatment of Hypertension in Patients With Cushing's Syndrome
por: Barbot, Mattia, et al.
Publicado: (2019)

Toward a Diagnostic Score in Cushing's Syndrome
por: Braun, Leah T., et al.
Publicado: (2019)

Circulating microRNA Expression in Cushing’s Syndrome
por: Vetrivel, Sharmilee, et al.
Publicado: (2021)

Cyclic Cushing’s Syndrome – A Diagnostic Challenge
por: Świątkowska-Stodulska, Renata, et al.
Publicado: (2021)

Individualized medical treatment options in Cushing disease
por: Gilis-Januszewska, Aleksandra, et al.
Publicado: (2022)

Cushing’s syndrome is associated with altered adipokine profile
por: Dadej, Daniela, et al.
Publicado: (2022)

Case Report: Reversible cabergoline-associated cardiac valvulopathy post drug discontinuation
por: Yedinak, Chris G., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_rstcu4hc4n4ndijplmssue5k0r